Image

Neoadjuvant Therapy of HAIC?GEMOX? Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors?NEO-ERA-01 Study

Exploring new treatment for liver cancer before surgery: NEO-ERA-01 Study.

Recruiting
18-75 years
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is testing a treatment for intrahepatic cholangiocarcinoma, a type of liver cancer, that has a high risk of coming back after surgery. The treatment uses a combination of drugs: hepatic arterial perfusion chemotherapy (delivers medicine directly to the liver), Lenvatinib (a medicine that stops cancer cells from growing), and Adebrelimab (a type of immunotherapy that helps the immune system fight cancer). Participants will undergo 2-4 cycles of this drug combination before having surgery to remove the cancer.

  • The study includes 2-4 cycles of treatment followed by surgery.
  • Participants must be between 18-75 years old and pass certain health tests.
  • Eligibility requires a cancer diagnosis confirmed by a doctor.
Print
Study details
    Biliary Tract Carcinoma

NCT06208462

The First Affiliated Hospital with Nanjing Medical University

24 January 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.